Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord. ALS usually affects people between the ages of 40 and 70, but this doesn’t mean that it cannot be diagnosed at other ages. Unfortunately, around 20,000 American citizens are estimated to develop the disease…
Amyotrophic lateral sclerosis (ALS) is a disease that progressively shuts down your muscles by attacking certain cells in the brain and spinal cord needed to keep our muscles moving. Eventually, patients will lose their mobility, have trouble moving, walking, swallowing and even breathing. In this video, shared by …
Amyotrophic lateral sclerosis (ALS) is a disease that progressively shuts down your muscles by attacking certain cells in the brain and spinal cord needed to keep our muscles moving. Eventually, patients will lose their mobility, have trouble moving, walking, swallowing and even breathing. In this video, shared by …
In this video from Philly Philms, watch how the evolution of technological devices are now providing a way for people with low mobility in their upper-body to be able to communicate with other people with the help of assistive technology. Amyotrophic lateral sclerosis (ALS)…
Tecla is for anyone who finds it difficult to use an iOS or Android touchscreen device. This includes people who have their mobility limited, especially their upper-body – such as amyotrophic lateral sclerosis (ALS) patients. Get Tecla is the youtube channel of The Tecla…
Scientists at Umeå University have found that superoxide dysmutase (SOD1), a protein that may cause amylotophic lateral sclerosis (ALS) spreads and clumps when injected into mice. The protein deposits also cause ALS-like symptoms. The report, titled “Two superoxide dismutase prion strains transmit amyotrophic lateral sclerosis-like disease” appeared May 3, 2016…
In this video by NathanAndRose, watch Rose describe the amyotrophic lateral sclerosis disorder (ALS) and the American organization (ALS Association) which is searching for the cure. Learn more about ALS here: https://bit.ly/ALSNewsToday…
The Target ALS Foundation, a collaborative research consortium, received a $5 million matching-gift donation from Biogen to help establish the foundation’s new Industry Fund for ALS Research, supporting a network of private-public research laboratories working to develop effective treatments and, ideally, a cure for amyotrophic lateral sclerosis (ALS). “Biogen is deeply committed to ALS…
University of Bern researchers have discovered that the synaptic protein Homer-3 is linked to the death of Purkinje motor neurons in Spinocerebellar ataxia type 1 (SCA1), a motor neuron disease that, like amyotrophic lateral sclerosis (ALS), is characterized by extensive motor neuron loss. The study, titled “Impaired mTORC1-Dependent Expression of…
The winners of the DREAM ALS Stratification Prize4Life Challenge were recently announced by Prize4Life, Sage Bionetworks and the DREAM community. The challenge is a global data analysis competition designed to computationally determine the different subgroups of patients who suffer from amyotrophic lateral sclerosis (ALS). There is currently…
